We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Software Platform Identifies and Characterizes Proteins and Peptides

By Biotechdaily staff writers
Posted on 21 May 2008
A software platform was developed for the identification and characterization of proteins and peptides from mass spectrometry (MS) data.

Called Phenyx, the software was specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic result assessment, while offering a flexible user-experience and adaptable architecture. More...
It is available in multiple formats and installation configurations to insure its availability to the entire scientific community.

Phenyx was developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland) in collaboration with the Swiss Institute of Bioinformatics (SIB). GeneBio SA and GE Healthcare Life Sciences Latin America (GEHC-LS; São Paulo, Brazil) have announced a distribution agreement whereby GEHC-LS will distribute GeneBio's Phenyx MS identification platform throughout Latin America. This deal follows the long lasting relationship between GE Healthcare and GeneBio concerning the distribution of GeneBio's Melanie imaging platform.

Under the terms of the agreement, GEHC-LS will distribute Phenyx within the Latin American market as the exclusive MS software component of their product range. The deal encompasses GeneBio's Phenyx (for MS-MS identification), Aldente (for PMF analysis) as well as Phenyx's Daemon and other MS related software products that GeneBio will be marketing in the future.


Related Links:
Phenyx
Geneva Bioinformatics
GE Healthcare

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.